Lockheed Martin Golden Dome and PAC-3 Contract Surge: Why the $186 Billion Backlog Makes the 22% Pullback a Buy Opportunity

Table of Contents

Lockheed Martin (NYSE: LMT) has spent most of 2026 in the penalty box. The stock changed hands at $540.33 on June 13, sitting roughly 22% below its 52-week high of $692, after a Q1 earnings miss, F-16 production delays, and lingering concerns about fixed-price development charges scared away the marginal buyer. And yet, in the past two weeks alone, the company has racked up nearly $10 billion in new defense awards — anchored by a $4.8 billion undefinitized contract action for PAC-3 missile production — and now carries a backlog of $186.4 billion that is roughly 2.5 times last year’s revenue. That mismatch between sentiment and order book is exactly the kind of setup long-term investors should be hunting for, and it is the reason we are publishing this Lockheed Martin Golden Dome stock thesis 2026 today.

The case is not subtle. Lockheed sits at the structural center of three of the largest defense capital cycles in a generation: the U.S.-led Golden Dome integrated missile defense architecture, the Patriot/PAC-3 munitions ramp that allies are still ordering at a record pace, and the F-35 sustainment franchise that is finally translating tail-feed growth into earnings. None of these are short-cycle stories. All three are funded, contracted, or both. With the stock trading at 16.87x consensus forward earnings of $32.03 — a discount to its own ten-year average and to Northrop Grumman and RTX — the asymmetry is real.

This article will work through what the company actually does, where the industry is heading, why Lockheed’s moat is unusually deep even by defense-prime standards, what the financials look like once you strip out the headline distortions, where fair value sits, and what could break the thesis. The three things you should remember when you finish reading: the $186.4 billion backlog gives revenue visibility through the end of the decade, the Golden Dome architecture is structurally favorable to Lockheed’s combat-proven product lines (PAC-3, THAAD, Aegis, hypersonics interceptors), and the current valuation is pricing in a margin profile that the next two years of mix shift should not deliver.

1. Company Overview

Lockheed Martin is the largest pure-play defense contractor in the world. The company reported TTM revenue of $75.11 billion and TTM net income of $4.79 billion, with a market capitalization of $124.58 billion at the June 13 close. EPS came in at $20.65 over the trailing twelve months, with consensus forward EPS at $32.03 — implying a meaningful step-up as Q4 2025 fixed-price charges roll off the comparison and the munitions and F-35 sustainment ramps roll on.

The business is organized into four segments. Aeronautics is the largest, dominated by the F-35 Lightning II program. F-35 is the only fifth-generation Western fighter in serial production and the only multi-role stealth platform certified for all three roles — air-to-air, deep-strike, and intelligence/surveillance/reconnaissance — across U.S. Air Force, Navy, and Marine Corps versions. Lockheed has delivered well over 1,100 jets and the program is currently in Lot 18 production, with a long sustainment tail that is now producing the segment’s most reliable earnings stream. In Q1 2026, F-35 sustainment alone added roughly $325 million in higher revenue and a $130 million favorable profit adjustment.

Missiles and Fire Control (MFC) is the segment that matters most for the next two years. It houses PAC-3, THAAD, JASSM, LRASM, GMLRS, HIMARS, and the company’s hypersonics programs. PAC-3 in particular has become the linchpin of allied air defense in Ukraine, the Middle East, and Indo-Pacific theaters, and the recent $4.8 billion undefinitized contract represents one of the largest single-line munitions awards Lockheed has received in recent years. Management has telegraphed that PAC-3 production volume is on a multi-year ramp from roughly 500 units per year toward 650-plus, supported by capacity expansion in Camden, Arkansas and Dallas.

Rotary and Mission Systems (RMS) anchors Sikorsky helicopters, Aegis Combat System integration, and a growing piece of the C5ISR market. Aegis is particularly relevant to the Golden Dome thesis because the integrated air and missile defense architecture being built out under SHIELD and related programs leans heavily on Lockheed-supplied radars and command-and-control nodes.

Space carries the bulk of the company’s classified work, the GPS III/IIIF satellite franchise, Orion (the crewed Artemis spacecraft), and an increasing share of national security space launches via United Launch Alliance. The segment is also where Lockheed’s space-based interceptor and missile-tracking work for Golden Dome will flow through. In Q1 2026, Space delivered a $514.4 million contract modification for space vehicles, on top of its ongoing classified backlog.

Revenue mix is structurally diverse:

Segment	TTM Revenue Share	Key Programs
Aeronautics	~40%	F-35, F-16, C-130J
Missiles & Fire Control	~17%	PAC-3, THAAD, JASSM, hypersonics
Rotary & Mission Systems	~22%	Sikorsky, Aegis, C5ISR
Space	~21%	GPS III, Orion, classified

The customer base is concentrated but durable. The U.S. Department of Defense and its international partners account for the bulk of revenue, with the U.S. government alone representing roughly 73% of sales. The top institutional holders — Vanguard, BlackRock, State Street — own a combined ~25% of the float, and insider ownership is modest, which is typical for a mature defense prime. Importantly, Lockheed has returned $4.0 billion to shareholders over the trailing twelve months via dividends and buybacks, and the dividend has been raised for more than two decades of consecutive annual increases.

2. Industry Analysis

2-1. Market Size and Growth Trajectory

Global defense spending crossed $2.7 trillion in 2025 according to SIPRI, the largest real-terms total since the end of the Cold War. The U.S. accounts for roughly 38% of that figure, and the FY2026 defense topline — including OCO/supplemental funding — is on a path toward $895 billion, anchored by procurement and Research, Development, Test and Evaluation (RDT&E) accounts that together command around $310 billion. Within that envelope, missile defense and munitions are the two fastest-growing line items, both of which compound at low-double-digits annually in the FYDP.

International demand is the multiplier. NATO members have substantially exceeded the 2% of GDP defense floor and many — Poland, Germany, the Baltics, the Nordics — are now spending 3% or above. The recent NATO defense industrial strategy explicitly prioritized ground-based air defense, long-range strike, and air-launched munitions, all categories in which Lockheed holds dominant or duopoly positions. Japan has now formally adopted Tomahawk and is ramping JASSM-ER. South Korea, Australia, and the UAE are deepening PAC-3 buys. Indo-Pacific Command’s posture review continues to drive Tier-1 munitions demand.

Where in the cycle? The defense procurement super-cycle that began with the 2022 inflection is in the acceleration phase. The 2024-2026 vintage of contract awards is now flowing into 2026-2030 deliveries. Multi-year procurement authorities — designed precisely to give primes the confidence to invest in factory capacity — are in force for PAC-3, GMLRS, and several other priority programs. This is structurally different from the 2010-2014 cycle, which was constrained by sequestration. We are in the opposite regime.

2-2. Structural Growth Drivers

Driver 1: Golden Dome and the integrated missile defense build-out. In January 2025, President Trump signed an executive order directing the Department of Defense to design and build the Golden Dome, an integrated nationwide defense system covering ballistic, cruise, and hypersonic missile threats across 3.8 million square miles. The program is now in early-architecture procurement, with the Pentagon’s broader Golden Dome competition involving more than 1,000 firms and budget allocations approaching $151 billion across the program’s lifecycle. Lockheed is one of a handful of SHIELD architecture contract awardees and a central player in the Pentagon’s hypersonic defense roadmap. Space Force has tasked twelve firms with space-based interceptor (SBI) prototype work totaling up to $3.2 billion across 20 contracts, and Lockheed’s combination of GPS III, classified space, and missile-defense kill-chain assets makes it a default integrator. Importantly, Golden Dome is not a single-prime program — it is a system-of-systems — but the share of contract value that flows through Lockheed’s existing product lines (PAC-3, THAAD, Aegis BMD, hypersonic interceptors) is substantial. Even if Lockheed captures only ~15% of program-of-record value over the next decade, that is roughly $20 billion in incremental backlog beyond the current $186 billion.

Driver 2: Munitions ramp — PAC-3, JASSM, GMLRS, Tomahawk. The structural under-procurement of munitions in the post-Cold War period has fully reversed. Ukraine has consumed in three years what U.S. procurement assumed would last decades, and replenishment alone implies a multi-year production surge. PAC-3 is the cleanest expression of this. The $4.8 billion undefinitized contract action announced in Q1 2026 supports an accelerated PAC-3 missile ramp plan that is expected to take annual production from approximately 500 units to over 650, with a stretch goal in the 700-750 range as Camden capacity comes online. Pricing is firm-fixed but reflects multi-year inflation indexing. Each PAC-3 MSE missile carries a unit price north of $4 million; the math on a sustained 650-unit annual run rate is straightforward. Similar dynamics apply to GMLRS (HIMARS rockets), JASSM-ER, and LRASM. International demand for PAC-3 alone now exceeds U.S. demand in some quarters.

Driver 3: F-35 sustainment becomes the real F-35 story. The F-35 production franchise gets most of the headlines, but sustainment is where the cash flows. With more than 1,100 aircraft delivered and a 30-plus-year operational life, the addressable lifecycle services revenue dwarfs the production revenue. In Q1 2026, F-35 sustainment delivered higher year-over-year sales and a $130 million favorable profit adjustment — the kind of recurring, services-style margin that the market under-appreciates because it is buried in a segment that also includes lumpy production. As the global fleet expands from ~1,100 toward an eventual ~3,500 aircraft, sustainment becomes a recurring, software-like revenue stream that benefits from operating leverage and pricing power. Block 4 modernization, which has been the primary source of fixed-price development pain, is now past the worst of its execution risk.

2-3. Competitive Landscape

The U.S. defense prime market is effectively an oligopoly, but the segment-level competitive picture is more nuanced.

Company	TTM Revenue	TTM Op. Margin	Market Cap	Backlog	Key Moat
Lockheed Martin (LMT)	$75.1B	9.8%	$124.6B	$186.4B	F-35 monopoly, PAC-3/THAAD
RTX (RTX)	$87.6B	~11%	$202B	$237B	Patriot system, Pratt & Whitney
Northrop Grumman (NOC)	$42.0B	~10%	$73B	$87B	B-21, Sentinel ICBM
General Dynamics (GD)	$50.6B	~10%	$80B	$96B	Combat vehicles, submarines

RTX has higher revenue and a slightly stronger backlog, but commercial aerospace (Pratt & Whitney, Collins) carries cyclical risk that Lockheed’s pure-play defense profile avoids. Northrop has the prestige programs (B-21, Sentinel ICBM) but both are fixed-price development with execution risk that has bitten margins in three of the last five quarters. General Dynamics’ Marine Systems is structurally strong but the broader Combat Systems mix carries lower margin power than Lockheed’s munitions and F-35 sustainment mix.

Why is Lockheed better positioned than peers for the next 24 months? Three reasons. First, the company’s product mix is shifting toward higher-margin recurring revenue (F-35 sustainment, munitions production) and away from the fixed-price development drag that hurt 2024-2025 results. Second, the PAC-3/THAAD/JASSM franchise is the cleanest play on the global munitions ramp, with the steepest production curve and the longest-running multi-year procurement authority. Third, Golden Dome — by design — flows through systems Lockheed already produces, which means incremental revenue does not require winning brand-new platforms.

3. Economic Moat Analysis

Moat Type 1: Efficient Scale and Switching Costs in Sole-Source Platforms

The F-35 is the textbook efficient-scale moat in defense. The platform is the only Western fifth-generation fighter in production and the only one certified across air-to-air, deep-strike, and ISR roles. Eighteen partner nations have signed Letters of Acceptance covering more than 3,500 aircraft over the program’s life. Once a country has integrated F-35 into its fleet, the switching cost is effectively infinite — pilot training, basing infrastructure, weapons integration, software updates, simulator networks, and most importantly the classified mission systems data, all flow exclusively through Lockheed. There is no second-source. Even a hypothetical Chinese or European next-gen fighter cannot displace F-35 within its 30-year sustainment lifecycle. This is the textbook definition of an efficient-scale moat: the market is large enough for one provider to earn returns on capital, but not large enough to support a second.

The PAC-3 missile sits on a similar foundation. Lockheed is the sole producer of the PAC-3 missile family, including the CRI baseline and the MSE variant that has become the global air defense standard. Allied air defense doctrine — Polish Wisla, German Patriot, Saudi Patriot, Japanese Patriot — has been built around PAC-3 specifically. The U.S. Army’s Patriot battalions cannot be re-equipped on short notice with any other interceptor. As of the latest reporting, the unit price on PAC-3 MSE is roughly $4-5 million, and the order book stretches well into the 2030s. Switching costs at the platform level make this moat structurally durable: even after a counterprovider develops a comparable interceptor (which would take 10-plus years), allied integration and logistics tails would keep PAC-3 demand intact for the program’s full lifecycle.

Moat Type 2: Intangibles and Regulatory Barriers

Defense primes operate behind a wall of intangible barriers that are difficult to fully appreciate from the outside. Lockheed maintains active facility clearances for Special Access Programs (SAPs) covering hundreds of classified projects, with a workforce of more than 20,000 cleared engineers operating in compartmented environments. Replicating that infrastructure — physical, cyber, and personnel — would take a new entrant fifteen to twenty years and tens of billions of dollars in fixed investment. The clearance backlog alone is a moat: bringing a single engineer to TS/SCI clearance with polygraph access takes 12-18 months on average.

The regulatory wall is equally formidable. The International Traffic in Arms Regulations (ITAR), export controls, foreign disclosure requirements, and the Defense Federal Acquisition Regulation Supplement (DFARS) cybersecurity maturity model (CMMC) collectively create a compliance burden that new entrants cannot absorb. This is why genuine new defense primes are extraordinarily rare — Anduril is the first new prime in roughly thirty years, and even it has had to acquire existing cleared facilities to scale.

Moat Durability Assessment

The relevant question is whether Lockheed’s moats hold over a 5-10-year horizon. We see three credible risks and three reasons they are manageable.

Risk 1: New-prime disruption. Anduril, Palantir, SpaceX, and others are credibly building share in classified software, autonomy, and launch. Counter: these are share-gain plays in adjacent categories, not direct displacement of F-35, PAC-3, or THAAD. Lockheed is partnering rather than fighting in many of these areas (e.g., recent Lockheed-Anduril cooperation on autonomous systems).

Risk 2: Platform obsolescence — could F-35 be made obsolete by NGAD or unmanned systems? Counter: the F-35 sustainment tail is contractually locked through at least the 2050s, and even an accelerated NGAD fielding timeline would not displace the F-35 fleet before the 2040s.

Risk 3: Procurement reform or Congressional scrutiny of fixed-price contracts. Counter: this is a margin risk, not a moat risk. Lockheed’s response — leaning into firm-fixed price only for proven, mature products and pushing back on fixed-price development — is the right one. Q1 2026 management commentary explicitly addressed this discipline.

Net: the moat holds. The company’s franchise positions in F-35, PAC-3, and integrated air and missile defense are not under credible threat at a 5-10-year horizon.

투자 분석 이미지 — Photo by Timothy Holmes on Unsplash

4. Financial Analysis

Revenue and earnings trajectory:

Metric	2023	2024	2025	TTM 2026
Revenue ($B)	67.6	71.0	74.0	75.1
Operating Income ($B)	8.5	7.0	6.5	7.4
Net Income ($B)	6.9	5.3	5.0	4.8
Operating Margin	12.6%	9.9%	8.8%	9.8%
Diluted EPS ($)	27.55	22.31	21.49	20.65

The 2024-2025 EPS compression is the elephant in the room. It is driven almost entirely by a single category of items: fixed-price development contract charges, most prominently on F-35 Block 4 modernization and a classified aeronautics program. These charges totaled roughly $1.7 billion in 2024 and another ~$1.4 billion in 2025. They are not recurring operating expenses; they are one-time true-ups against percentage-of-completion accounting on programs the company is now closer to finishing.

What matters for forward earnings is the mix shift that is already underway. The 39.29% EPS growth that consensus captures for “this year” — i.e., FY2026 — reflects two things: (1) the Q4 2025 charges drop out of the comparison, and (2) the munitions ramp and F-35 sustainment growth carry positive operating leverage into 2026. Consensus forward EPS of $32.03 implies operating margins recovering toward 10.5-11% — not quite back to the 2023 peak, but materially above the trailing twelve-month figure.

Key operating metrics:

– Backlog: $186.4 billion at the end of Q1 2026, equivalent to ~2.5 years of revenue. Management expects to convert approximately 34% over the next 12 months and 58% over 24 months.
– PAC-3 unit deliveries: on track for ~500 in FY2026, ramping toward 650+ in FY2027 as Camden expansion comes online.
– F-35 deliveries: 156 aircraft in 2025; guidance of 170-190 in 2026.
– F-35 sustainment revenue growth: running at high single-digits YoY, with a $130 million favorable profit adjustment in Q1.

Balance sheet:

– Cash and equivalents: approximately $2.4 billion at the end of Q1 2026.
– Total debt: roughly $19.6 billion. Debt-to-equity of 2.76 is high in absolute terms but normal for a defense prime with stable, contracted cash flows. Net debt / EBITDA sits around 2.1x.
– Operating cash flow: $7.0 billion over the trailing twelve months.
– Free cash flow: approximately $5.3 billion TTM after capex of roughly $1.7 billion. FCF was depressed in Q1 2026 due to working-capital timing on advance payments; full-year guidance remains in the $6.0-6.5 billion range.

Return on capital:

– ROE: 67.64% (TTM) — high, but partly a function of share repurchases shrinking the equity base. Even after normalizing for the buyback effect, returns on tangible capital remain comfortably above mid-teens.
– ROA: 8.27% — healthy for an asset-intensive defense manufacturer.
– ROIC sits in the high-teens range, which is the cleanest read on actual capital efficiency.

The path to margin recovery is the central financial story. Three things compound. First, the fixed-price development tail rolls off. Second, the high-margin services revenue (F-35 sustainment, hypersonics programs that are now in production rather than development) grows faster than the corporate average. Third, the munitions ramp delivers volume leverage on a fixed cost base — Camden’s PAC-3 line carries strong incremental margins above 500 units/year.

5. Valuation

We use a forward P/E framework with a cross-check against EV/EBITDA and a defensive DCF.

Forward P/E approach. Consensus EPS for the next twelve months is $32.03. Lockheed’s ten-year average forward P/E is approximately 17.5x. The current 16.87x forward multiple is, by that historical anchor, modestly cheap. If we apply a normalized 18x forward multiple — reflecting the higher-quality earnings mix as fixed-price development drag fades — fair value is $32.03 × 18 = $576.50 per share. That implies roughly 6.7% upside from the $540.33 spot. A more constructive 19x multiple, justified by the Golden Dome optionality and the firmness of the $186.4 billion backlog, gets us to $32.03 × 19 = $608.60, or 12.6% upside.

EV/EBITDA cross-check. Enterprise value at $540.33 share price (market cap $124.58B + net debt ~$17.2B = $141.8B). TTM EBITDA approximately $8.9 billion, with consensus FY2026 EBITDA closer to $11.5 billion as charges abate. Current EV/EBITDA (forward) sits at ~12.3x, which compares to peer-average forward EV/EBITDA of ~13.0x. Applying 13x to forward EBITDA gives EV of $149.5B, equity value of $132.3B, or ~$574 per share. The two methods converge near $575.

DCF backstop. A defensive DCF using a 9% discount rate, 5% revenue CAGR through 2030 tapering to 3% terminal growth, and operating margins recovering to 10.5% by 2027 and holding flat thereafter, generates a value in the $605-630 range. The consensus analyst target of $626.79 sits at the higher end of that range.

Scenario analysis:

Scenario	Forward EPS	Multiple	Fair Value	vs. Spot
Bear: margins stall, Golden Dome share underwhelms	$29.50	15.0x	$443	-18%
Base: margins recover to 10.5%, normal Golden Dome share	$32.03	18.5x	$593	+9.7%
Bull: margins expand to 11.5%, outsized Golden Dome capture	$34.50	20.0x	$690	+27.7%

We agree with the consensus analyst target of $626.79 directionally — it sits between our base and bull cases — but we view the base case as more likely than the bull at a 12-month horizon, given how much of the Golden Dome program value flow is back-end loaded toward 2027-2030 rather than 2026. Our 12-month target is $595 per share, implying approximately 10% upside before dividends. Including the ~2.4% dividend yield, the 12-month total-return target is roughly 12.5%.

This is not a multibagger setup. It is a high-quality compounder buying at a sensible valuation with embedded optionality. The reason to own LMT at $540 is not that the stock should double — it is that the downside is well-defended by the backlog and dividend, while the upside path to $625-700 is funded and contracted.

6. Risk Factors

Risk 1: Fixed-price development charges recur. Lockheed took roughly $1.4 billion in fixed-price development charges in 2025, primarily on F-35 Block 4 modernization and a classified aeronautics program. While management has explicitly stated the worst is behind on Block 4 and has tightened underwriting on new fixed-price work, the company still has roughly $20-25 billion of fixed-price development exposure across the portfolio. A single bad program — particularly on a classified scope-of-work where the customer can change requirements — can produce a multi-hundred-million-dollar charge in a single quarter. The market reaction would be sharp. Mitigating factor: the worst-affected program (Block 4) is in late-stage execution, and management’s commentary on Q1 has been notably more confident about cost-to-complete than it was twelve months ago.

Risk 2: Procurement delays and continuing-resolution drag. Congress has resorted to continuing resolutions (CRs) in 9 of the last 12 fiscal years. Under a CR, new program starts are forbidden and contract execution timelines stretch right. For Lockheed, the most exposed programs are Golden Dome ramp-up awards (early-stage funding lines) and certain munitions multi-year procurement extensions. If the FY2027 budget is delivered late or under a yearlong CR, some Golden Dome contract awards that we have modeled into 2027 could slip into 2028. Revenue impact would be visible but not catastrophic — perhaps $1.0-1.5 billion in revenue timing — but it would weigh on the stock until visibility returns.

Risk 3: Geopolitical de-escalation. This is the genuinely difficult risk to handicap. A meaningful ceasefire in Ukraine, a Middle East de-escalation, or an Indo-Pacific cooling-off would not eliminate defense demand — replenishment alone would carry the next 24-36 months — but it would compress the multiple investors are willing to pay for defense names and could push out international order timing. Mitigating factor: U.S.-China structural competition is the deep driver of Indo-Pacific defense spending, and there is no realistic path to a near-term reversal there. NATO 3%+ commitments are also now hard-codified in member-state budgets through 2030.

Risk 4 (additional, monitor-only): F-35 sustainment competition. The U.S. Air Force has periodically explored options to recompete portions of the F-35 sustainment scope. Any meaningful share loss here would compress the highest-quality earnings stream Lockheed has. We see this as low-probability over the next 3-5 years because of the depth of Lockheed’s mission-system IP, but it is the long-tail risk to watch.

7. Conclusion and Exit Plan

Lockheed Martin at $540.33 is a Buy. Not a table-pounding multibagger story, but a high-quality defense compounder available at a sensible valuation, with an unusually strong combination of contracted backlog, structural demand drivers, and shareholder-returns discipline. The $186.4 billion backlog gives the kind of revenue visibility that is rare anywhere in the equity market. The Golden Dome architecture, the PAC-3 munitions ramp, and F-35 sustainment growth all line up to support margin recovery into 2026 and 2027. The setup is asymmetric: limited downside protected by backlog and dividend, meaningful upside to $625-700 funded by programs already in execution.

Entry strategy. Initiate a starter position at current levels ($530-545). Add on weakness toward the $500 area, which would represent roughly a 28% drawdown from the 52-week high and would offer a forward P/E closer to 15.6x — an unusually cheap entry for a defense prime of this quality. A full position should be in place below $520.

Exit conditions:

– Target achieved: trim 30-40% of the position at $595 (our base-case target). Trim another 30% at $645 if the Golden Dome contract flow surprises to the upside in 2026.
– Fundamental break — exit: if FY2026 reports two consecutive quarters of fresh fixed-price development charges exceeding $300 million each, or if PAC-3 production output falls more than 10% below the 500-unit/year target, the margin-recovery thesis is broken and the position should be exited regardless of price.
– Geopolitical break — partial exit: in the event of a credible, durable ceasefire in both the Ukraine and Middle East theaters, trim 25-30% of the position as multiple compression becomes likely.
– Time-based: reassess fully in 6 months, or immediately after the next two quarterly earnings prints — both of which will provide important read-throughs on margin trajectory and Golden Dome contract flow.

Summary table:

Item	Detail
Company	Lockheed Martin Corporation (LMT)
Current Price	$540.33
12-month Target Price	$595 (base) / $690 (bull) / $443 (bear)
Upside to Base Target	+10% (+12.5% with dividend)
Rating	Buy
Key Thesis	$186.4B backlog + Golden Dome + PAC-3 ramp deliver visible margin recovery into 2026-2027 at a forward P/E of 16.87x — sensible valuation with embedded optionality
Main Risk	Recurring fixed-price development charges and Continuing-Resolution-driven contract timing delays
Dividend Yield	~2.4%
Position Sizing	Starter at $530-545; add to full position below $520

Disclaimer

This article is for informational purposes only and does not constitute investment advice. All data sourced from public filings (Lockheed Martin Q1 2026 10-Q, FY2025 10-K), analyst reports, and news as of the publication date (June 14, 2026). Forward-looking statements are subjective and may differ materially from realized outcomes. Invest at your own discretion and consult a licensed financial advisor before making investment decisions.